Analysis for Invesco DB Commodity Index Tracking Fund
Analysis summary
Invesco DB Commodity Index Tracking Fund (DBC) currently has a total score of 47 points, placing it in the neutral range. The score is made up of Performance (37), Stability (65) and Trend (46). The profile is clearly uneven: Stability stands out while Performance lags.
Performance scores 37 points (weak). Least weak metric: 5Y return at 45.6 %. Main drag: 3Y return at -1.8 %.
Stability scores 65 points (strong). Key strength: volatility (365d, annualized) at 16.6 %. Main drag: max drawdown (10Y) at -67.1 %. That indicates very deep historical drawdowns. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 46 points (neutral). Key strength: trend strength at 0.73. Weaker signal: Price is about 0.8 % above SMA50.
Overall, the picture is mixed: Stability does the heavy lifting while Performance holds the score back. On a metric level, volatility (365d, annualized) stands out, while 3Y return lags.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does Invesco DB Commodity Index Tracking Fund fit best in FoxScore?
- Invesco DB Commodity Index Tracking Fund fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.
- How meaningful is the available history for Invesco DB Commodity Index Tracking Fund?
- Invesco DB Commodity Index Tracking Fund currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.